应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
AMGN 安进
休市中 08-23 16:00:00 EDT
328.80
+4.27
+1.32%
盘后
328.31
-0.49
-0.15%
19:42 EDT
最高
331.29
最低
325.38
成交量
177.11万
今开
326.27
昨收
324.53
日振幅
1.82%
总市值
1,767亿
流通市值
1,762亿
总股本
5.37亿
成交额
5.83亿
换手率
0.33%
流通股本
5.36亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
专利战升级背后:安进三星再次对簿公堂,生物类似药市场生变?
医药经济报 · 08-23 20:44
专利战升级背后:安进三星再次对簿公堂,生物类似药市场生变?
安进下跌1.24%,报325.075美元/股
金融界 · 08-23 01:00
安进下跌1.24%,报325.075美元/股
安进上涨1.21%,报325.323美元/股
金融界 · 08-19
安进上涨1.21%,报325.323美元/股
安进上涨1.25%,报326.78美元/股
金融界 · 08-15
安进上涨1.25%,报326.78美元/股
引言-对医疗保险药品降价的反应
Reuters · 08-15
引言-对医疗保险药品降价的反应
美国公布医疗保险药品谈判价格
Reuters · 08-15
美国公布医疗保险药品谈判价格
美国预计首次医疗保险药品价格谈判将节省 60 亿美元
Reuters · 08-15
美国预计首次医疗保险药品价格谈判将节省 60 亿美元
实时市场-在不确定的环境中,高质量可能提供稳定的基础
Reuters · 08-15
实时市场-在不确定的环境中,高质量可能提供稳定的基础
安进2024财年第二财季实现净利润7.46亿美元,同比减少45.90%
自选股智能写手 · 08-13
安进2024财年第二财季实现净利润7.46亿美元,同比减少45.90%
动荡市场中投资哪些股票较安全?这8只股有良好的业绩记录,且估值吸引
老虎资讯综合 · 08-12
动荡市场中投资哪些股票较安全?这8只股有良好的业绩记录,且估值吸引
安进(AMGN.US)&阿斯利康(AZN.US)“First-in-class”疗法获FDA突破性疗法认定 治疗COPD
智通财经 · 08-12
安进(AMGN.US)&阿斯利康(AZN.US)“First-in-class”疗法获FDA突破性疗法认定 治疗COPD
安进上涨3.08%,报322.12美元/股
金融界 · 08-09
安进上涨3.08%,报322.12美元/股
双安进入调改期 老百货转型终点是社区生活新空间
北京商报 · 08-08
双安进入调改期 老百货转型终点是社区生活新空间
RBC Capital上调安进目标价至362美元
格隆汇 · 08-08
RBC Capital上调安进目标价至362美元
BUZZ--美国股票走势-雅培实验室、美敦力、Axon
Reuters · 08-08
BUZZ--美国股票走势-雅培实验室、美敦力、Axon
美国研究综述-安进、Atkore、MoneyLion
Reuters · 08-08
美国研究综述-安进、Atkore、MoneyLion
安进(AMGN)跌4.79% 二季度净利同比跌近5成 调整后每股收益略低于预期
金吾财讯 · 08-07
安进(AMGN)跌4.79% 二季度净利同比跌近5成 调整后每股收益略低于预期
异动解读 | 安进二季度净利大跌46% 股价盘中重挫5%
异动解读 · 08-07
异动解读 | 安进二季度净利大跌46% 股价盘中重挫5%
安进下跌5.45%,报311.015美元/股
金融界 · 08-07
安进下跌5.45%,报311.015美元/股
安进盘中异动 快速下挫5.03%
自选股智能写手 · 08-07
安进盘中异动 快速下挫5.03%
暂无数据
公司概况
公司名称:
安进
所属市场:
NASDAQ
上市日期:
--
主营业务:
Amgen Inc是一家生物技术公司。该公司发现,开发,制造和提供各种人类治疗药物。该公司专注于医疗需求亟待满足的领域,并利用其专业知识来努力寻求改善人们健康状况与生活质量的解决方案。该公司主要经营人类治疗业务。该公司的市场产品组合包括Aranesp,Enbrel,Prolia (denosumab),Neulasta (pegfilgrastim),Otezla,XGEVA, Aranesp (darbepoetin alfa),KYPROLIS,Repatha (evolocumab),Nplate (romiplostim),Vectibix (panitumab),MVASI (bevacizumab-awwb),Parsabiv (etelcalcetide),EPOGEN (epoetin alfa ),KANJINTI (trastuzumab-Anns),BLINCYTO (blinatumomab),Aimovig (erenumab-aooe),EVENITY (romosozumab-aqqg),AMGEVITATM (adalimumab),Sensipar/Mimpara (cinacalcet),NEUPOGEN (filgrastim),IMLYGIC (talimogene laherparepvec),Corlanor (ivabradine),KYPROLIS (carfilzomib),Maridebart cafraglutide,(infliximab-axxq),Evenity,LumaKras,Nplate和XGeva等。
发行价格:
--
{"stockData":{"symbol":"AMGN","market":"US","secType":"STK","nameCN":"安进","latestPrice":328.8,"timestamp":1724443200000,"preClose":324.53,"halted":0,"volume":1771092,"hourTrading":{"tag":"盘后","latestPrice":328.31,"preClose":328.8,"latestTime":"19:42 EDT","volume":132327,"amount":43507579.3,"timestamp":1724456527708},"delay":0,"floatShares":535846298,"shares":537329220,"eps":5.799574,"marketStatus":"休市中","marketStatusCode":7,"change":4.27,"latestTime":"08-23 16:00:00 EDT","open":326.27,"high":331.29,"low":325.38,"amount":583429159.39392,"amplitude":0.018211,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":5.799574,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724659200000},"adr":0,"listingDate":423288000000,"adjPreClose":324.53,"adrRate":0,"dividendRate":0.026642,"preHourTrading":{"tag":"盘前","latestPrice":326.53,"preClose":324.53,"latestTime":"09:29 EDT","volume":593,"amount":192770.64321,"timestamp":1724419777688},"postHourTrading":{"tag":"盘后","latestPrice":328.31,"preClose":328.8,"latestTime":"19:42 EDT","volume":132327,"amount":43507579.3,"timestamp":1724456527708},"volumeRatio":1.209832890542114,"impliedVol":0.2579,"impliedVolPercentile":0.5833},"requestUrl":"/m/hq/s/AMGN/tweets","defaultTab":"tweets","newsList":[{"id":"2461659943","title":"专利战升级背后:安进三星再次对簿公堂,生物类似药市场生变?","url":"https://stock-news.laohu8.com/highlight/detail?id=2461659943","media":"医药经济报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461659943?lang=zh_cn&edition=full","pubTime":"2024-08-23 20:44","pubTimestamp":1724417094,"startTime":"0","endTime":"0","summary":"安进声称,三星生物的生物类似药侵犯了其34项专利,要求法院下令禁止三星生产和销售这些药物,同时要求赔偿未明确的经济损失。安进和三星生物再次对簿公堂,凸显了生物制药领域竞争的激烈程度。捍卫百亿美元市场安进狙击三星生物据了解,安进向法院表示,三星生物已向美国FDA递交申请许可,以销售普罗力和安加维的生物类似物。最后,安进将三星生物依那西普生物类似药上市推迟至2029年。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408232052349f4c6028&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408232052349f4c6028&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0002141913.USD","BK4585","IE0009355771.USD","AMGN","LU0868494617.USD","LU1057294990.SGD","IE00B2B36J28.USD","LU0122379950.USD","IE00BJJMRZ35.SGD","LU2112291526.USD","LU2242646821.SGD","BK4581","IE00B4R5TH58.HKD","LU1983299246.USD","LU0320765992.SGD","LU1061106388.HKD","BK4566","BK4533","LU2242652126.USD","SG9999001440.SGD","BK4139","LU0109394709.USD","BK4534","BK4588","IE00BFTCPJ56.SGD","LU1023059063.AUD","LU0058720904.USD","IE00BJT1NW94.SGD","LU0889565916.HKD","LU0289739699.SGD","LU1571399168.USD"],"gpt_icon":0},{"id":"2461323276","title":"安进下跌1.24%,报325.075美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2461323276","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461323276?lang=zh_cn&edition=full","pubTime":"2024-08-23 01:00","pubTimestamp":1724346059,"startTime":"0","endTime":"0","summary":"8月23日,安进(AMGN)盘中下跌1.24%,截至01:00,报325.075美元/股,成交1.99亿美元。财务数据显示,截至2024年06月30日,安进收入总额158.35亿美元,同比增长20.96%;归母净利润6.33亿美元,同比减少85.0%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/08/23010042633706.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK4566","LU1571399168.USD","BK4139","BK4585","BK4533","IE00B2B36J28.USD","IE0009355771.USD","LU0058720904.USD","SG9999001440.SGD","LU0320765992.SGD","LU2242652126.USD","LU0868494617.USD","LU0889565916.HKD","BK4581","LU0122379950.USD","LU1057294990.SGD","AMGN","LU1061106388.HKD","IE00BJT1NW94.SGD","BK4534","LU1983299246.USD","LU0109394709.USD","IE00BFTCPJ56.SGD","LU0289739699.SGD","IE00BJJMRZ35.SGD","BK4588","LU2112291526.USD","LU1023059063.AUD","IE0002141913.USD","LU2242646821.SGD","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2460037273","title":"安进上涨1.21%,报325.323美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2460037273","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460037273?lang=zh_cn&edition=full","pubTime":"2024-08-19 22:10","pubTimestamp":1724076608,"startTime":"0","endTime":"0","summary":"8月19日,安进(AMGN)盘中上涨1.21%,截至22:10,报325.323美元/股,成交3336.72万美元。财务数据显示,截至2024年06月30日,安进收入总额158.35亿美元,同比增长20.96%;归母净利润6.33亿美元,同比减少85.0%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/08/19221042499935.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["IE0002141913.USD","BK4585","IE0009355771.USD","AMGN","LU0868494617.USD","LU1057294990.SGD","IE00B2B36J28.USD","LU0122379950.USD","IE00BJJMRZ35.SGD","LU2112291526.USD","LU2242646821.SGD","BK4581","IE00B4R5TH58.HKD","LU1983299246.USD","LU0320765992.SGD","LU1061106388.HKD","BK4566","BK4533","LU2242652126.USD","SG9999001440.SGD","BK4139","LU0109394709.USD","BK4534","BK4588","IE00BFTCPJ56.SGD","LU1023059063.AUD","LU0058720904.USD","IE00BJT1NW94.SGD","LU0889565916.HKD","LU0289739699.SGD","LU1571399168.USD"],"gpt_icon":0},{"id":"2459151471","title":"安进上涨1.25%,报326.78美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2459151471","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459151471?lang=zh_cn&edition=full","pubTime":"2024-08-15 23:16","pubTimestamp":1723734994,"startTime":"0","endTime":"0","summary":"8月15日,安进(AMGN)盘中上涨1.25%,截至23:16,报326.78美元/股,成交9262.8万美元。财务数据显示,截至2024年06月30日,安进收入总额158.35亿美元,同比增长20.96%;归母净利润6.33亿美元,同比减少85.0%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/08/15231642409472.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU0320765992.SGD","BK4566","BK4139","LU1023059063.AUD","LU2112291526.USD","IE00BFTCPJ56.SGD","BK4585","IE00B2B36J28.USD","IE00BJT1NW94.SGD","BK4581","BK4588","SG9999001440.SGD","LU0889565916.HKD","AMGN","LU1571399168.USD","IE0009355771.USD","BK4534","IE00B4R5TH58.HKD","LU0109394709.USD","LU0868494617.USD","LU0122379950.USD","IE0002141913.USD","LU1057294990.SGD","LU2242652126.USD","LU0058720904.USD","BK4533","LU0289739699.SGD","LU1983299246.USD","LU1061106388.HKD","IE00BJJMRZ35.SGD","LU2242646821.SGD"],"gpt_icon":0},{"id":"2459424102","title":"引言-对医疗保险药品降价的反应","url":"https://stock-news.laohu8.com/highlight/detail?id=2459424102","media":"Reuters","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459424102?lang=zh_cn&edition=full","pubTime":"2024-08-15 21:05","pubTimestamp":1723727136,"startTime":"0","endTime":"0","summary":" 路透8月15日 - 美国政府周四表示,已通过谈判将美国老年人医疗保险计划中 10 种最畅销处方药的价格下降了多达 79%,从而结束了与制药商长达数月的史无前例的讨论。卡马拉-哈里斯副总统\"今天的声明将改变全美许多人的生活\" \"我们不会止步于此\"\"作为我们医疗保险药品价格谈判计划的一部分,每年还将选择更多的处方药\"。\"保险计划及其药房福利管理者对患者支付的 Eliquis 费用负有最终责任\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1883839398.USD","LU1244550221.USD","PFE","AMGN","BK4581","LU0943347566.SGD","BK4139","LU1221951046.USD","LU0553294199.USD","IE0002141913.USD","IE00BJLML261.HKD","IE00BFTCPJ56.SGD","MRK","LU0321505868.SGD","LU0985481810.HKD","BK4592","LU0861579265.USD","BK4504","LU0640476718.USD","LU0237698245.USD","LU0211331839.USD","BMY","LU2112291526.USD","LU1267930490.SGD","JNJ","LU0689472784.USD","LU0889566641.SGD","LU1066051225.USD","LU0985320562.USD","LU1941712264.USD","LU1267930573.SGD","IE0004445239.USD","ABBV","LU1059921491.USD","LU1064131342.USD","SG9999011175.SGD","LU1551013342.USD","LU0882574139.USD","LU0097036916.USD","LU1551013425.SGD","LU0882574055.USD","LU0820561818.USD","SG9999003800.SGD","LU1196500208.SGD","LU0823416689.USD","IE0009355771.USD","NVO","LU0079474960.USD","LU0198837287.USD","LU1221951129.SGD"],"gpt_icon":1},{"id":"2459599440","title":"美国公布医疗保险药品谈判价格","url":"https://stock-news.laohu8.com/highlight/detail?id=2459599440","media":"Reuters","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459599440?lang=zh_cn&edition=full","pubTime":"2024-08-15 19:14","pubTimestamp":1723720461,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 路透8月15日 - 美国 周四公布了有史以来第一次处方药谈判的 最终价格,其中默克公司的 糖尿病药物Januvia的降价幅度最大,达到79%。政府为其医疗保险计划(Medicare)中 10 种最昂贵的药品谈判了 (link) 价格,该计划服务于 65 岁以上的美国人和残疾人,覆盖人数达 6600 万。这些药物包括百时美施贵宝 和辉瑞 的畅销血液稀释剂Eliquis以及默克公司的Januvia。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1585245621.USD","LU0211328371.USD","LU0310800379.SGD","LU1066051811.HKD","BK4534","LU1551013425.SGD","LU0985481810.HKD","LU1670710661.SGD","AMGN","LU0237698245.USD","LU0820561909.HKD","LU0079474960.USD","ABBV","LU0096364046.USD","LU0006306889.USD","LU1267930573.SGD","IE0002270589.USD","LU2112291526.USD","LU1934455863.HKD","LU1571399168.USD","LU1623119135.USD","IE00BJLML261.HKD","LU0211327993.USD","LU0471298694.HKD","BMY","BK4007","MRK","LU1069344957.HKD","JNJ","LU0225771236.USD","IE00B1BXHZ80.USD","BK4533","LU0882574139.USD","LU1261432733.SGD","IE00B19Z3B42.SGD","BK4516","LU1670711123.USD","PFE","LU1670710588.SGD","LU0289739699.SGD","BK4532","IE0002141913.USD","BK4585","LU1074936037.SGD","LU0882574055.USD","LU0689472784.USD","IE0034235303.USD","LU1983299246.USD","LU0795875169.SGD"],"gpt_icon":1},{"id":"2459410889","title":"美国预计首次医疗保险药品价格谈判将节省 60 亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459410889","media":"Reuters","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459410889?lang=zh_cn&edition=full","pubTime":"2024-08-15 17:00","pubTimestamp":1723712437,"startTime":"0","endTime":"0","summary":"美国政府表示,医疗保险主要为 65 岁及以上的美国人提供服务,该计划所覆盖的人群也将在当年节省 15 亿美元的处方药自付费用。哈里斯在参议院的投票中以平票通过了允许药品价格谈判的法律,没有共和党人支持这项法律。下一轮医疗保险药品价格谈判预计将包括另外 15 种药品,于二月份开始。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LLY","JNJ","LU0158827948.USD","PFE","BK4504","BMY","LU0889566641.SGD","LU1162221912.USD","LU1221951046.USD","MRK","LU2242646821.SGD","LU0265550946.USD","IE00B7SZLL34.SGD","LU1883839398.USD","NVO","LU1244550494.USD","LU0345770993.USD","LU0640476718.USD","IE00BK4W5M84.HKD","IE00B19Z3581.USD","LU2125154778.USD","LU2347655156.SGD","LU0738911758.USD","LU1032955483.USD","IE00BK4W5L77.USD","LU0985320562.USD","BK4588","IE00B2B36J28.USD","LU1196500208.SGD","LU1221951129.SGD","LU0949170772.SGD","LU2133065610.SGD","BK4581","LU1064131342.USD","LU0545039389.USD","LU0345770308.USD","LU0471298777.SGD","ABBV","BK4592","LU0320765059.SGD","LU1430594728.SGD","LU0170899867.USD","LU0320765489.SGD","LU1718418525.SGD","LU1059921491.USD","LU0029864427.USD","LU0070302665.USD","LU1267930730.SGD","AMGN","LU0672654240.SGD","IE00BN8TJ469.HKD"],"gpt_icon":1},{"id":"2459102063","title":"实时市场-在不确定的环境中,高质量可能提供稳定的基础","url":"https://stock-news.laohu8.com/highlight/detail?id=2459102063","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459102063?lang=zh_cn&edition=full","pubTime":"2024-08-15 00:37","pubTimestamp":1723653455,"startTime":"0","endTime":"0","summary":"您可以通过以下方式与我们分享您的观点 在不确定的环境中,高质量可能提供稳定的基础标普 500 指数 在仲夏创下一系列新高后,投资者的热情迅速减退,因为主要经济数据激起了沉睡已久的经济衰退担忧,以及对美联储政策立场可能落后于曲线的担忧。因此,我们认为,在市场继续消化迅速变得越来越不确定的投资环境时,投资者应该关注这类策略。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0426417589.USD","LU0234572021.USD","BK4573","SQQQ","IE00B1BXHZ80.USD","IE00BK4W5L77.USD","LU0080751232.USD","DJX",".SPX","LU0786609619.USD","LU0545562505.USD","LU0122379950.USD","DXD","LU0353189763.USD","LU0052756011.USD","LU0234570918.USD","IE00BSNM7G36.USD","LU1057294990.SGD","LU0198837287.USD","LU0289739699.SGD","IE0004091025.USD","QID",".IXIC","BRO","SDOW","BK4581","MNQmain","NQmain","AMGN","QLD","PSQ","BK4574","LU0265550946.USD","UDOW","DDM","APD","DOG","KR","IE0004086264.USD","IE00B4R5TH58.HKD","IE00BK4W5M84.HKD","LU",".DJI","LU0417517546.SGD","TQQQ","IE00BKPKM429.USD"],"gpt_icon":1},{"id":"2459182935","title":"安进2024财年第二财季实现净利润7.46亿美元,同比减少45.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459182935","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459182935?lang=zh_cn&edition=full","pubTime":"2024-08-13 00:17","pubTimestamp":1723479457,"startTime":"0","endTime":"0","summary":"8月13日,安进公布财报,公告显示公司2024财年第二财季净利润为7.46亿美元,同比减少45.90%;其中营业收入为83.33亿美元,同比增加19.90%,每股基本收益为1.39美元。从资产负债表来看,安进总负债849.82亿美元,其中短期债务55.28亿美元,资产负债比为1.07,流动比率为1.27。机构评级:截至2024年8月13日,当前有22家机构对安进目标价做出预测,其中目标均价为324.34美元,其中最低目标价为180.00美元,最高目标价为381.00美元。安进还拥有不断增长的生物仿制药产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408130017409f24e20f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408130017409f24e20f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMGN"],"gpt_icon":0},{"id":"1143503109","title":"动荡市场中投资哪些股票较安全?这8只股有良好的业绩记录,且估值吸引","url":"https://stock-news.laohu8.com/highlight/detail?id=1143503109","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143503109?lang=zh_cn&edition=full","pubTime":"2024-08-12 10:40","pubTimestamp":1723430413,"startTime":"0","endTime":"0","summary":"对于希望在动荡市场中寻找安全投资机会的投资者来说,有一系列大盘股——特别是医疗保健领域的公司,是有吸引力的投资选择。Humira 用于治疗严重类风湿性关节炎、克罗恩病和溃疡性结肠炎,其第二季度全球净收入较 2023 年同期下降 29.8%,原因是来自廉价生物仿制药的竞争继续拖累销售。不过,该公司管理层表示,部分患者正在转向 AbbVie 的免疫治疗药物 Skyrizi 和 Rinvoq。该股票今年迄今已上涨超过21%,大幅超越了大盘的回报率。","market":"us","thumbnail":"https://community-static.tradeup.com/news/b925dee54e4c3c1d4390f884b109adb0","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/b925dee54e4c3c1d4390f884b109adb0"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"动荡市场中哪些股票较安全?这8只股票有着良好的业绩记录,且估值颇具吸引力","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV","AFL","TMUS","AZO","COR","PKG","UNH","AMGN"],"gpt_icon":1},{"id":"2458646574","title":"安进(AMGN.US)&阿斯利康(AZN.US)“First-in-class”疗法获FDA突破性疗法认定 治疗COPD","url":"https://stock-news.laohu8.com/highlight/detail?id=2458646574","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458646574?lang=zh_cn&edition=full","pubTime":"2024-08-12 09:53","pubTimestamp":1723427625,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,日前,安进公司在2024年第二季度财报中表示,该公司与阿斯利康合作开发的“first-in-class”单抗Tezspire获得FDA授予的突破性疗法认定,作为附加维持疗法,治疗中度至极重度慢性阻塞性肺病患者,这些患者具有嗜酸性粒细胞表型。两家公司正在计划在COPD患者中启动3期临床试验。Tezepelumab是一款“first-in-class”人源性、靶向抗胸腺基质淋巴细胞生成素的单克隆抗体。该疗法在2021年12月获美国FDA批准作为附加维持疗法,治疗12岁以上儿童和成人严重哮喘患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1162735.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0868494617.USD","LU2112291526.USD","LU2242652126.USD","AZN","IE0002141913.USD","IE00B4R5TH58.HKD","LU1061106388.HKD","BK4588","IE00B2B36J28.USD","BK4533","BK4568","IE00BJJMRZ35.SGD","BK4581","BK4139","LU0289739699.SGD","LU1829250122.USD","LU0122379950.USD","AMGN","LU1057294990.SGD","LU1571399168.USD","LU1023059063.AUD","SG9999001440.SGD","BK4007","BK4566","IE00BJT1NW94.SGD","IE0009355771.USD","IE00BFTCPJ56.SGD","BK4585","LU2242646821.SGD","BK4534","LU0320765992.SGD","LU0889565916.HKD","LU0058720904.USD","LU0109394709.USD","LU2236285917.USD"],"gpt_icon":0},{"id":"2458340943","title":"安进上涨3.08%,报322.12美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2458340943","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458340943?lang=zh_cn&edition=full","pubTime":"2024-08-09 01:43","pubTimestamp":1723139008,"startTime":"0","endTime":"0","summary":"8月9日,安进(AMGN)盘中上涨3.08%,截至01:43,报322.12美元/股,成交3.44亿美元。财务数据显示,截至2024年06月30日,安进收入总额158.35亿美元,同比增长20.96%;归母净利润6.33亿美元,同比减少85.0%。大事提醒:8月6日,安进2024财年中报归属股东应占溢利6.33亿美元,同比下降85%,基本每股收益1.18美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/08/09014342195590.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["IE0009355771.USD","LU2112291526.USD","LU0889565916.HKD","LU0289739699.SGD","LU2242646821.SGD","LU1571399168.USD","IE00B4R5TH58.HKD","LU0109394709.USD","BK4534","SG9999001440.SGD","BK4588","BK4139","IE00B2B36J28.USD","LU0320765992.SGD","IE00BJJMRZ35.SGD","BK4581","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU0122379950.USD","LU1061106388.HKD","BK4585","IE0002141913.USD","LU0058720904.USD","BK4533","LU2242652126.USD","LU1057294990.SGD","LU0868494617.USD","LU1023059063.AUD","AMGN","BK4566"],"gpt_icon":0},{"id":"2457395223","title":"双安进入调改期 老百货转型终点是社区生活新空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2457395223","media":"北京商报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457395223?lang=zh_cn&edition=full","pubTime":"2024-08-08 18:57","pubTimestamp":1723114648,"startTime":"0","endTime":"0","summary":"近日,双安商场宣布即将进入调改期,将从辐射京西商业的地标项目转变为辐射周边3—5公里的品质社区商业。胡绮年介绍,此次调整,双安商场将聚焦生活体验领域。基于双安商场的百货基因,此次调整并非变为购物中心,而是让周边居民和消费者在此能够形成一个生态圈。中国商业联合会专家委员会委员赖阳指出,传统百货改造一定要跳出“百货思维”,围绕“生活方式中心”和“社区生活第三空间”进行改造。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408081858009f1a4da4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408081858009f1a4da4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0868494617.USD","LU2242652126.USD","BK4533","LU0058720904.USD","BK4581","BK4534","LU1057294990.SGD","BK4566","BK4588","SG9999001440.SGD","LU0122379950.USD","LU1023059063.AUD","LU2112291526.USD","IE00B4R5TH58.HKD","LU1571399168.USD","IE0009355771.USD","AMGN","LU1061106388.HKD","LU0109394709.USD","IE00BJJMRZ35.SGD","LU0889565916.HKD","BK4585","LU0320765992.SGD","LU2242646821.SGD","BK4139","IE0002141913.USD","LU0289739699.SGD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","IE00BJT1NW94.SGD"],"gpt_icon":0},{"id":"2457361555","title":"RBC Capital上调安进目标价至362美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457361555","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457361555?lang=zh_cn&edition=full","pubTime":"2024-08-08 17:21","pubTimestamp":1723108914,"startTime":"0","endTime":"0","summary":"RBC Capital:将安进的目标价从332美元上调至362美元,维持“跑赢大市”评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808172155af969476&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808172155af969476&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMGN","RY"],"gpt_icon":0},{"id":"2457875841","title":"BUZZ--美国股票走势-雅培实验室、美敦力、Axon","url":"https://stock-news.laohu8.com/highlight/detail?id=2457875841","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457875841?lang=zh_cn&edition=full","pubTime":"2024-08-08 02:47","pubTimestamp":1723056454,"startTime":"0","endTime":"0","summary":" * Eikon 个股走势搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 8月7日 - 华尔街主要股指周三上扬,受助于大型股的上涨,以及日本最高决策者在上周意外加息后转为鸽派,这在一定程度上引发了全球市场的剧烈波动。美东时间14:35 ,道琼斯工业平均指数 下跌0.52%,报38,793.6 点。标普500指数 下跌0.53%,报5,212.5点;纳斯达克综合指数 下跌0.77%,报16,240.061点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SMCI","MDT","PODD","DIS","DJX","PGNY","SDOW","ABT","QID","BKR","CVX","DXCM","ILMN",".SPX","AXON","NEXT","NYT","PETQ","CYRX","REAL","BUZZ","NQmain","GTHX","UDOW","VCYT","TECH","OSCR","CART","DDM",".IXIC",".DJI","TNDM","LYFT","TSVT","XOM","SWTX","ROK","IEP","CRL","APA","DXD","EMR","AMGN","PSQ","INSP"],"gpt_icon":1},{"id":"2457821758","title":"美国研究综述-安进、Atkore、MoneyLion","url":"https://stock-news.laohu8.com/highlight/detail?id=2457821758","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457821758?lang=zh_cn&edition=full","pubTime":"2024-08-08 00:34","pubTimestamp":1723048497,"startTime":"0","endTime":"0","summary":" 路透8月7日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价,其中包括安进公司、Atkore公司和MoneyLion公司。要闻 * 安进公司 :加拿大皇家银行将目标价从332美元上调至362美元 * Atkore Inc :加拿大皇家银行将其评级从 \"跑赢大盘 \"下调至 \"行业表现\"。* MoneyLion :Needham将目标价从100美元下调至70美元 * Progyny Inc :BTIG将其评级从 \"买入 \"下调至 \"中性\"。股票条目按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABL","AVNT","IE00B19Z4B17.USD","AMWL","ANAB","AZPN","AMGN","ARCT","ADTN","AZTA","AHCO","BK4548","ADUS","AXON","CAR","ASH","LU1023059063.AUD","AIRG","IE00BJT1NW94.SGD","AGL","BK4109","ASPI","ARMK","BBWI","BK4006","IE0031619046.USD","LU0122379950.USD","ALAB","AVB","LU1989773731.SGD","AMH","BEAM","GOLF","AESI","BWIN","AEE","AEP","ALGT","ACM","BAX","ATKR","ACAD","ATI","CELH","LU0289739699.SGD","IE00B7SZLL34.SGD","LU1057294990.SGD","ACA","IE00B3S45H60.SGD","ALIT"],"gpt_icon":1},{"id":"2457825992","title":"安进(AMGN)跌4.79% 二季度净利同比跌近5成 调整后每股收益略低于预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2457825992","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457825992?lang=zh_cn&edition=full","pubTime":"2024-08-07 23:23","pubTimestamp":1723044228,"startTime":"0","endTime":"0","summary":"金吾财讯 | 安进(AMGN)股价震荡下行,截至发稿,跌4.79%,报313.19美元,成交额4.45亿美元。安进二季度净利润为7.46亿美元,较上年同期下降了46%;营收达到83.9亿美元,较去年同期增长20%,超出市场预期的83.7亿美元。该增长主要得益于公司治疗骨质疏松症的药物Prolia和用于降低胆固醇的药物Repatha等成熟产品的销售。调整后的每股收益为4.97美元,略低于市场预期的5美元。此外,公司预计全年的资本支出将达到13亿美元,这一数字超过了之前估计的大约11亿美元。","market":"us","thumbnail":"https://static.szfiu.com/news/20210810/MzE4MDg0MTAxNw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/MzE4MDg0MTAxNw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"278684","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU1061106388.HKD","LU2242646821.SGD","BK4566","BK4533","IE0009355771.USD","IE00BJT1NW94.SGD","LU0058720904.USD","IE00BJJMRZ35.SGD","LU0320765992.SGD","LU0122379950.USD","LU0889565916.HKD","LU1571399168.USD","SG9999001440.SGD","LU2242652126.USD","LU1057294990.SGD","LU2112291526.USD","LU0289739699.SGD","IE00B2B36J28.USD","BK4581","LU0868494617.USD","AMGN","IE0002141913.USD","BK4534","BK4585","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU0109394709.USD","LU1023059063.AUD","BK4139"],"gpt_icon":0},{"id":"1149995812","title":"异动解读 | 安进二季度净利大跌46% 股价盘中重挫5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1149995812","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149995812?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:56","pubTimestamp":1723038976,"startTime":"0","endTime":"0","summary":"美国生物制药公司安进8月7日盘中股价大跌5.05%,报312.41美元/股。此前公司公布的第二季度财报显示,尽管营收同比增长20%至83.9亿美元,超出市场预期,但净利润同比大幅下滑46%至7.46亿美元,调整后每股收益4.97美元,也低于分析师预期的5美元。分析人士指出,尽管安进的营收表现强劲,但利润率下滑和费用支出增加引发了市场对公司盈利能力的担忧,加之对MariTide前景的不确定性,导致股价在盘中大幅下挫。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMGN"],"gpt_icon":0},{"id":"2457223849","title":"安进下跌5.45%,报311.015美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2457223849","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457223849?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:32","pubTimestamp":1723037567,"startTime":"0","endTime":"0","summary":"8月7日,安进(AMGN)开盘下跌5.45%,截至21:32,报311.015美元/股,成交8247.57万美元。财务数据显示,截至2024年06月30日,安进收入总额158.35亿美元,同比增长20.96%;归母净利润6.33亿美元,同比减少85.0%。大事提醒:8月6日,安进2024财年中报归属股东应占溢利6.33亿美元,同比下降85%,基本每股收益1.18美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/08/07213242156420.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["IE0002141913.USD","BK4585","IE0009355771.USD","AMGN","LU0868494617.USD","LU1057294990.SGD","IE00B2B36J28.USD","LU0122379950.USD","IE00BJJMRZ35.SGD","LU2112291526.USD","LU2242646821.SGD","BK4581","IE00B4R5TH58.HKD","LU0320765992.SGD","LU1061106388.HKD","BK4566","BK4533","LU2242652126.USD","SG9999001440.SGD","BK4139","LU0109394709.USD","BK4534","BK4588","IE00BFTCPJ56.SGD","LU1023059063.AUD","LU0058720904.USD","IE00BJT1NW94.SGD","LU0889565916.HKD","LU0289739699.SGD","LU1571399168.USD"],"gpt_icon":0},{"id":"2457419849","title":"安进盘中异动 快速下挫5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457419849","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457419849?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:32","pubTimestamp":1723037551,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日21时32分,安进股票出现异动,股价急速跳水5.03%。安进股票所在的制药行业中,整体跌幅为1.14%。安进于 2006 年推出了首款癌症治疗药物 Vectibix,并销售骨强化药物 Prolia/Xgeva和 Evenity。安进还拥有不断增长的生物仿制药产品组合。消息层面,截至21时32分,安进股票正面舆情新闻比例71.43%。《安进Q2营收超预期 上调全年资本支出预期以增加减肥药投资》资讯为影响安进的重要信息。安进表示,目前正在进行的试验的初步数据预计将于2024年底公布。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080721323196824c84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080721323196824c84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1061106388.HKD","BK4533","BK4139","IE00B2B36J28.USD","LU0289739699.SGD","BK4566","IE0009355771.USD","IE0002141913.USD","LU1057294990.SGD","LU0058720904.USD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU0122379950.USD","LU1023059063.AUD","LU0320765992.SGD","LU2242646821.SGD","IE00BJJMRZ35.SGD","LU2242652126.USD","LU1571399168.USD","LU2112291526.USD","LU0109394709.USD","BK4588","IE00B4R5TH58.HKD","BK4534","LU0868494617.USD","BK4581","BK4585","AMGN","LU0889565916.HKD","SG9999001440.SGD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.amgen.com","stockEarnings":[{"period":"1week","weight":0.0229},{"period":"1month","weight":-0.0203},{"period":"3month","weight":0.0751},{"period":"6month","weight":0.137},{"period":"1year","weight":0.2813},{"period":"ytd","weight":0.1416}],"compareEarnings":[{"period":"1week","weight":0.0141},{"period":"1month","weight":0.0386},{"period":"3month","weight":0.0617},{"period":"6month","weight":0.1069},{"period":"1year","weight":0.2867},{"period":"ytd","weight":0.1827}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Amgen Inc是一家生物技术公司。该公司发现,开发,制造和提供各种人类治疗药物。该公司专注于医疗需求亟待满足的领域,并利用其专业知识来努力寻求改善人们健康状况与生活质量的解决方案。该公司主要经营人类治疗业务。该公司的市场产品组合包括Aranesp,Enbrel,Prolia (denosumab),Neulasta (pegfilgrastim),Otezla,XGEVA, Aranesp (darbepoetin alfa),KYPROLIS,Repatha (evolocumab),Nplate (romiplostim),Vectibix (panitumab),MVASI (bevacizumab-awwb),Parsabiv (etelcalcetide),EPOGEN (epoetin alfa ),KANJINTI (trastuzumab-Anns),BLINCYTO (blinatumomab),Aimovig (erenumab-aooe),EVENITY (romosozumab-aqqg),AMGEVITATM (adalimumab),Sensipar/Mimpara (cinacalcet),NEUPOGEN (filgrastim),IMLYGIC (talimogene laherparepvec),Corlanor (ivabradine),KYPROLIS (carfilzomib),Maridebart cafraglutide,(infliximab-axxq),Evenity,LumaKras,Nplate和XGeva等。","yearOnYearQuotes":[{"month":1,"riseRate":0.634146,"avgChangeRate":0.032606},{"month":2,"riseRate":0.463415,"avgChangeRate":-0.003118},{"month":3,"riseRate":0.512195,"avgChangeRate":0.019417},{"month":4,"riseRate":0.463415,"avgChangeRate":-0.001307},{"month":5,"riseRate":0.536585,"avgChangeRate":0.024998},{"month":6,"riseRate":0.512195,"avgChangeRate":0.004729},{"month":7,"riseRate":0.761905,"avgChangeRate":0.052458},{"month":8,"riseRate":0.595238,"avgChangeRate":0.004793},{"month":9,"riseRate":0.536585,"avgChangeRate":0.003724},{"month":10,"riseRate":0.536585,"avgChangeRate":0.021341},{"month":11,"riseRate":0.634146,"avgChangeRate":0.022436},{"month":12,"riseRate":0.658537,"avgChangeRate":0.050861}],"exchange":"NASDAQ","name":"安进","nameEN":"Amgen"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"安进(AMGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供安进(AMGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"安进,AMGN,安进股票,安进股票老虎,安进股票老虎国际,安进行情,安进股票行情,安进股价,安进股市,安进股票价格,安进股票交易,安进股票购买,安进股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"安进(AMGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供安进(AMGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}